255869-27-3 Usage
Uses
Used in Pharmaceutical Research and Drug Development:
5-allyl-6-methyl-2-phenylpyrimidin-4-ol is used as a pharmaceutical compound for its potential therapeutic applications. Its structural features make it a promising candidate for the development of new drugs and treatments.
Used in Organic Synthesis:
In the field of organic synthesis, 5-allyl-6-methyl-2-phenylpyrimidin-4-ol is used as a building block for the production of various drugs and bioactive compounds, contributing to the creation of novel and effective pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 255869-27-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,5,8,6 and 9 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 255869-27:
(8*2)+(7*5)+(6*5)+(5*8)+(4*6)+(3*9)+(2*2)+(1*7)=183
183 % 10 = 3
So 255869-27-3 is a valid CAS Registry Number.
255869-27-3Relevant academic research and scientific papers
NURR1:RXR ACTIVATING COMPOUNDS FOR SIMULTANEOUS TREATMENT OF SYMPTOMS AND PATHOLOGY OF PARKINSON'S DISEASE
-
Page/Page column 37; 39, (2017/08/01)
The invention provides a series of substituted aryl pyrimidine compounds and the use of these compounds as therapeutics to treat or prevent neurodegenerative disorders, including Parkinson's disease. Compounds of the invention are also able to treat the s
New Ugi-Smiles-metathesis strategy toward the synthesis of pyrimido azepines
El Kaim, Laurent,Grimaud, Laurence,Oble, Julie
, p. 5835 - 5838 (2008/02/09)
(Chemical Equation Presented) A new strategy involving Ugi-Smiles coupling followed by ring-closure metathesis is described herein for the preparation of pyrimidine-fused heterocyclic scaffolds. The scope of this sequence is presented in relation with the
